Organogenesis Holdings, Inc. (ORGO)
2.66
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
2.665
0.00 (0.00%)
Pre-Market: 20:00
Organogenesis Holdings EPS Diluted (Quarterly) : -0.4394 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pyxis Oncology, Inc. | -0.3667 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.16M |
| Revenue (Quarterly) | 37.23M |
| Total Expenses (Quarterly) | 90.38M |
| Enterprise Value | 457.83M |
| Gross Profit Margin (Quarterly) | -2.46% |
| Profit Margin (Quarterly) | -142.8% |
| Earnings Yield | -5.97% |
| Operating Earnings Yield | 3.41% |
| Normalized Earnings Yield | -4.098 |